title: Will MRI screening deliver the expected survival advantage in BRCA 1 carriers?
authors.forename: L J
authors.initials: LJ
authors.lastname: Hamilton
authors.forename: A J
authors.initials: AJ
authors.lastname: Evans
authors.forename: E J
authors.initials: EJ
authors.lastname: Cornford
authors.forename: E A
authors.initials: EA
authors.lastname: Rakha
authors.forename: I O
authors.initials: IO
authors.lastname: Ellis
authors.forename: W D
authors.initials: WD
authors.lastname: Foulkes
mesh_terms: D000328:Adult; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology; D005260:Female; D019398:Genes, BRCA1; D006801:Humans; D008207:Lymphatic Metastasis; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008327:Mammography / Q000379:methods*; D008875:Middle Aged; D018295:Neoplasms, Basal Cell / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology / Q000556:secondary; D011379:Prognosis; D012680:Sensitivity and Specificity